View in EDS

Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.

Saved in:
Bibliographic Details
Title: Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.
Authors: Horwitz SM; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. horwitzs@mskcc.org.; New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY, USA. horwitzs@mskcc.org., Nirmal AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rahman J; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Xu R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Drill E; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Galasso N; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ganesan N; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Davey T; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hancock H; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Perez L; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Maccaro C; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bahgat A; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Marzouk E; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cathcart E; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Moskowitz A; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Noy A; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kumar A; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jacobsen E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Fisher DC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Mehta-Shah N; Department of Medicine, Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA., Kim YH; Division of Oncology, Stanford University, Stanford, CA, USA.; Department of Dermatology, Stanford University, Stanford, CA, USA., Khodadoust M; Division of Oncology, Stanford University, Stanford, CA, USA.; Department of Dermatology, Stanford University, Stanford, CA, USA., Kotlov N; BostonGene Corporation, Boston, MA, USA., Nikitina A; BostonGene Corporation, Boston, MA, USA., Kudryashova O; BostonGene Corporation, Boston, MA, USA., Zubareva V; BostonGene Corporation, Boston, MA, USA., Zornikova K; BostonGene Corporation, Boston, MA, USA., Shin N; BostonGene Corporation, Boston, MA, USA., Sorokina M; BostonGene Corporation, Boston, MA, USA., Degryse S; BostonGene Corporation, Boston, MA, USA., Postovalova E; BostonGene Corporation, Boston, MA, USA., Bagaev A; BostonGene Corporation, Boston, MA, USA., Hosszu K; Department of Pediatrics and Immune Discovery & Modeling Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., McAvoy D; Department of Pediatrics and Immune Discovery & Modeling Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Boelens JJ; Department of Pediatrics and Immune Discovery & Modeling Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wu W; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Ciantra Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Appelt JW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Trevisani C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Amaka S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Merck and Co., Rahway, NJ, USA., Vardhana SA; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. vardhans@mskcc.org.; New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY, USA. vardhans@mskcc.org.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. vardhans@mskcc.org.
Source: Nature medicine [Nat Med] 2024 Dec; Vol. 30 (12), pp. 3778.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39548313
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Horwitz+SM%22">Horwitz SM</searchLink>; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. horwitzs@mskcc.org.; New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY, USA. horwitzs@mskcc.org.<br /><searchLink fieldCode="AU" term="%22Nirmal+AJ%22">Nirmal AJ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rahman+J%22">Rahman J</searchLink>; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Xu+R%22">Xu R</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Drill+E%22">Drill E</searchLink>; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Galasso+N%22">Galasso N</searchLink>; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ganesan+N%22">Ganesan N</searchLink>; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Davey+T%22">Davey T</searchLink>; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Hancock+H%22">Hancock H</searchLink>; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Perez+L%22">Perez L</searchLink>; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Maccaro+C%22">Maccaro C</searchLink>; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Bahgat+A%22">Bahgat A</searchLink>; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Marzouk+E%22">Marzouk E</searchLink>; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Cathcart+E%22">Cathcart E</searchLink>; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Moskowitz+A%22">Moskowitz A</searchLink>; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Noy+A%22">Noy A</searchLink>; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Kumar+A%22">Kumar A</searchLink>; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Jacobsen+E%22">Jacobsen E</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Fisher+DC%22">Fisher DC</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Mehta-Shah+N%22">Mehta-Shah N</searchLink>; Department of Medicine, Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Kim+YH%22">Kim YH</searchLink>; Division of Oncology, Stanford University, Stanford, CA, USA.; Department of Dermatology, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Khodadoust+M%22">Khodadoust M</searchLink>; Division of Oncology, Stanford University, Stanford, CA, USA.; Department of Dermatology, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kotlov+N%22">Kotlov N</searchLink>; BostonGene Corporation, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Nikitina+A%22">Nikitina A</searchLink>; BostonGene Corporation, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kudryashova+O%22">Kudryashova O</searchLink>; BostonGene Corporation, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Zubareva+V%22">Zubareva V</searchLink>; BostonGene Corporation, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Zornikova+K%22">Zornikova K</searchLink>; BostonGene Corporation, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shin+N%22">Shin N</searchLink>; BostonGene Corporation, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sorokina+M%22">Sorokina M</searchLink>; BostonGene Corporation, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Degryse+S%22">Degryse S</searchLink>; BostonGene Corporation, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Postovalova+E%22">Postovalova E</searchLink>; BostonGene Corporation, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bagaev+A%22">Bagaev A</searchLink>; BostonGene Corporation, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hosszu+K%22">Hosszu K</searchLink>; Department of Pediatrics and Immune Discovery & Modeling Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22McAvoy+D%22">McAvoy D</searchLink>; Department of Pediatrics and Immune Discovery & Modeling Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Boelens+JJ%22">Boelens JJ</searchLink>; Department of Pediatrics and Immune Discovery & Modeling Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Wu+W%22">Wu W</searchLink>; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Ciantra+Z%22">Ciantra Z</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Appelt+JW%22">Appelt JW</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Trevisani+C%22">Trevisani C</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Amaka+S%22">Amaka S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Weinstock+DM%22">Weinstock DM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Merck and Co., Rahway, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Vardhana+SA%22">Vardhana SA</searchLink>; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. vardhans@mskcc.org.; New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY, USA. vardhans@mskcc.org.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. vardhans@mskcc.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2024 Dec; Vol. 30 (12), pp. 3778.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39548313
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41591-024-03404-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3778
    Titles:
      – TitleFull: Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Horwitz SM
      – PersonEntity:
          Name:
            NameFull: Nirmal AJ
      – PersonEntity:
          Name:
            NameFull: Rahman J
      – PersonEntity:
          Name:
            NameFull: Xu R
      – PersonEntity:
          Name:
            NameFull: Drill E
      – PersonEntity:
          Name:
            NameFull: Galasso N
      – PersonEntity:
          Name:
            NameFull: Ganesan N
      – PersonEntity:
          Name:
            NameFull: Davey T
      – PersonEntity:
          Name:
            NameFull: Hancock H
      – PersonEntity:
          Name:
            NameFull: Perez L
      – PersonEntity:
          Name:
            NameFull: Maccaro C
      – PersonEntity:
          Name:
            NameFull: Bahgat A
      – PersonEntity:
          Name:
            NameFull: Marzouk E
      – PersonEntity:
          Name:
            NameFull: Cathcart E
      – PersonEntity:
          Name:
            NameFull: Moskowitz A
      – PersonEntity:
          Name:
            NameFull: Noy A
      – PersonEntity:
          Name:
            NameFull: Kumar A
      – PersonEntity:
          Name:
            NameFull: Jacobsen E
      – PersonEntity:
          Name:
            NameFull: Fisher DC
      – PersonEntity:
          Name:
            NameFull: Mehta-Shah N
      – PersonEntity:
          Name:
            NameFull: Kim YH
      – PersonEntity:
          Name:
            NameFull: Khodadoust M
      – PersonEntity:
          Name:
            NameFull: Kotlov N
      – PersonEntity:
          Name:
            NameFull: Nikitina A
      – PersonEntity:
          Name:
            NameFull: Kudryashova O
      – PersonEntity:
          Name:
            NameFull: Zubareva V
      – PersonEntity:
          Name:
            NameFull: Zornikova K
      – PersonEntity:
          Name:
            NameFull: Shin N
      – PersonEntity:
          Name:
            NameFull: Sorokina M
      – PersonEntity:
          Name:
            NameFull: Degryse S
      – PersonEntity:
          Name:
            NameFull: Postovalova E
      – PersonEntity:
          Name:
            NameFull: Bagaev A
      – PersonEntity:
          Name:
            NameFull: Hosszu K
      – PersonEntity:
          Name:
            NameFull: McAvoy D
      – PersonEntity:
          Name:
            NameFull: Boelens JJ
      – PersonEntity:
          Name:
            NameFull: Wu W
      – PersonEntity:
          Name:
            NameFull: Ciantra Z
      – PersonEntity:
          Name:
            NameFull: Appelt JW
      – PersonEntity:
          Name:
            NameFull: Trevisani C
      – PersonEntity:
          Name:
            NameFull: Amaka S
      – PersonEntity:
          Name:
            NameFull: Weinstock DM
      – PersonEntity:
          Name:
            NameFull: Vardhana SA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2024 Dec
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1546-170X
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Nature medicine
              Type: main
ResultId 1